Bisphosphanates are used primarily for the prevention and treatment of osteoporosis, and are also indicated for osseous complications of malignancy. In addition to their bone resorption properties, ...

The use of bisphosphonates is linked to a reduced risk for fragility fractures in patients with polymyalgia rheumatica on ...

Bisphosphonates are medications that used to treat bone loss and are the most common agent to be prescribed for osteoporosis. These drugs can also reduce fracture risk in cases of previous fracture.

Bone tissue constitutes a fertile ‘soil’ for metastatic tumours, notably breast cancer. High concentrations of growth factors in bone matrix favour cancer cell proliferation and survival, and a ...

Compared with oral bisphosphonates, denosumab reduced fracture risk among treatment-experienced postmenopausal women with osteoporosis. Treatment with denosumab vs oral bisphosphonates is associated ...

Long-term use of osteoporosis drugs seems to change bones in a way that could lead to unusual leg fractures, according to two reports presented at a meeting of orthopedic surgeons. Doctors have ...

Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — Treatment with bisphosphonates does not always lead to a decrease in fracture rates among ...

Bisphosphonates, long used to strengthen bones, may prevent recurrence of early-stage breast cancer in postmenopausal women. In a way, developing low bone-mineral density may have been a lucky break ...

Labeling change adds warning about possible risks of long-term use of osteoporosis drugs The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk ...

Please provide your email address to receive an email when new articles are posted on . In an update to its guidance on primary osteoporosis, ACP recommended bisphosphonates as a first line of defense ...

BROOKLYN, NY — Authors of a new analysis say the US Food and Drug Administration (FDA) should consider revisiting its investigation of the atrial-fibrillation (AF) risk with certain osteoporosis drugs ...

Long-term bisphosphonate therapy can change bones at the microscopic level to make them more susceptible to the rare catastrophic transverse breaks known as atypical femoral fractures (AFFs), ...